Recombinant Lipoteichoic Acid (Pagibaximab Biosimilar) antibody

Catalog No. ABIN7597893

This Chimeric Chimeric antibody specifically detects Lipoteichoic Acid (Pagibaximab Biosimilar) . It exhibits reactivity toward Various Species.

Quick Overview for Recombinant Lipoteichoic Acid (Pagibaximab Biosimilar) antibody (ABIN7597893)

Target: Lipoteichoic Acid (Pagibaximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Various Species

Host: Chimeric

Clonality: Chimeric

Conjugate: Un-conjugated

Grade: Research Grade

Product Details

Expression System: Mammalian cells

Purpose: Research Grade Pagibaximab Biosimilar Antibody

Specificity: Staphylococcus Epidermidis Lipoteichoic Acid

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details

Target: Lipoteichoic Acid (Pagibaximab Biosimilar)

Alternative Name: Pagibaximab Biosimilar

Target Type: Biosimilar

Background: Staphylococcus Epidermidis Lipoteichoic Acid

CAS-No: 595566-61-3